Onkológia 4/2024
Use of nivolumab in solid tumours
Nivolumab is one of the revolutionary substances in oncology. It represents a breakthrough form of immunotherapy redefining the paradigm of the fight against malignancies. It activates the endogenous mechanisms of the immune system with the aim of selective recognition and elimination of malignant cells. It is currently used in a wide range of solid or hematological diagnoses.
Keywords: immunotherapy, nivolumab, monoclonal antibody, autoimmune disease, use in daily practice
